Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00121329 · ClinicalTrials.gov registry record · NA
4% Intrauterine Lidocaine Infusion for Pain Management in First Trimester Abortions
A NA study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT00121329 is a NA study that has completed, run by Oregon Health and Science University. The registered enrollment target is 80 participants.
The verdict
NCT00121329, a NA study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
Recent studies have investigated the use of local anesthetics (i.e. lidocaine, mepivacaine) to lessen the pain experienced with minor gynecologic procedures such as endometrial biopsy and office hysteroscopy. Local anesthetic injected into the uterine cavity has been demonstrated effective in some studies at decreasing patient pain associated with these intrauterine procedures at an anesthetic concentration of at least 2%. Based on this evidence, we hypothesized that an intrauterine lidocaine infusion may reduce patient pain during first trimester abortions.
Interventions
- DRUG Intrauterine lidocaine infusion 4%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Est. Completion | 2004-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00121329
The ClinicalTrials.gov registry entry for NCT00121329 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Intrauterine lidocaine infusion 4% is the first listed.
NCT00121329 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00121329 about?
NCT00121329 is a clinical study titled "4% Intrauterine Lidocaine Infusion for Pain Management in First Trimester Abortions". Recent studies have investigated the use of local anesthetics (i.e. lidocaine, mepivacaine) to lessen the pain experienced with minor gynecologic procedures such as endometrial biopsy and office hysteroscopy. Local anesthetic injected into the uterine cavity has been demonstrated effective in some s...
What is the current status of trial NCT00121329?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. Estimated completion is 2004-12.
What interventions are being tested in trial NCT00121329?
The interventions under investigation include: Intrauterine lidocaine infusion 4% (DRUG).
Who is sponsoring clinical trial NCT00121329?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.